| Identification | Back Directory | [Name]
Eleclazine | [CAS]
1443211-72-0 | [Synonyms]
GS6615
GS 6615
Eleclazine
GS6615;GS 6615
Eleclazine(GS-6615)
1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-(trifluoromethoxy)phenyl]-
4-(Pyrimidin-2-ylmethyl)-7-(4-(trifluoromethoxy)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one | [Molecular Formula]
C21H16F3N3O3 | [MDL Number]
MFCD28963966 | [MOL File]
1443211-72-0.mol | [Molecular Weight]
415.37 |
| Chemical Properties | Back Directory | [Melting point ]
72 - 74°C | [Boiling point ]
544.8±50.0 °C(Predicted) | [density ]
1.370±0.06 g/cm3(Predicted) | [storage temp. ]
2-8°C | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
0.37±0.13(Predicted) | [color ]
Pale Beige to Beige |
| Hazard Information | Back Directory | [Uses]
ELECLAZINE (cas# 1443211-72-0) is a late sodium current inhibitor and a phase II agent with demonstrated pre-clinical anti-ischemic and antiarrhythmic properties. | [storage]
-20°C |
|
|